Get startedLog in
    Picture of Novakand Pharma AB logo

    NOVKAN — Novakand Pharma AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Kancera Q3 Operating Loss Sek 10.5 Million

    Picture of Novakand Pharma AB logoNovakand Pharma AB
    17/11/2023 07:33
    Nov 17 (Reuters) - Kancera AB  KANC.ST :
    * INTERIM REPORT THIRD QUARTER JULY 1 – SEPTEMBER 30, 2023
KANCERA
AB (PUBL.), ORG.NO. 556806-8851
    * INTERIM REPORT THIRD QUARTER JULY 1 – SEPTEMBER 30, 2023
KANCERA
AB (PUBL.), ORG.NO. 556806-8851
    * Q3 OPERATING LOSS SEK 10.5 MILLION VERSUS LOSS SEK 10.7
MILLION
YEAR AGO
    * Q3 OPERATING LOSS SEK 10.5 MILLION VERSUS LOSS SEK 10.7
MILLION
YEAR AGO

Source text for Eikon:  ID:nMFN1Ht6HQ 
Further company coverage:  KANC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Novakand Pharma AB

    See all news